Elekta Ab (EKTAF) Stock Price, News & Analysis
Company Description
Elekta Ab (OTC Link: EKTAF) is classified in the medical devices industry within the Healthcare sector and carries a market capitalization of $2.0B.
EKTAF has gained 4.7% over the past year. Shares last traded at $5.25.
This page collects what Stock Titan holds for EKTAF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Elekta Ab (EKTAF) stock last closed at $5.25. Over the past 12 months, the stock has gained 4.7%. At a market capitalization of $2.0B, EKTAF is classified as a small-cap stock with approximately 368.6M shares outstanding.
Latest News
Elekta Ab has 6 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 2 with negative movement. Key topics include earnings, management. View all EKTAF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Elekta Ab (EKTAF) currently stands at 8.2 million shares, up 15.8% from the previous reporting period, representing 2.3% of the float. Since July 2025, short interest has increased by 50.7%. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Elekta Ab (EKTAF) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The ratio has shown significant volatility over the period, ranging from 304.9 to 1000.0 days.
EKTAF Company Profile & Sector Positioning
Elekta Ab (EKTAF) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing EKTAF often look at related companies in the same sector, including Elekta Ab (EKTAY), Nolato (NLTBF), Draegerwerk (DGWPF), Kuros Bioscience (CSBTF), and Vitrolife (VTRLY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate EKTAF's relative position within its industry.